TWD 60.0
(-8.95%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 1.15 Billion TWD | -1.53% |
2022 | 1.17 Billion TWD | 29.17% |
2021 | 911.82 Million TWD | 0.0% |
2020 | - TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 1.11 Billion TWD | 0.0% |
2024 Q1 | 1.11 Billion TWD | -4.14% |
2023 Q1 | 1.16 Billion TWD | -1.12% |
2023 Q3 | 1.15 Billion TWD | -0.42% |
2023 Q2 | 1.16 Billion TWD | 0.0% |
2023 FY | 1.15 Billion TWD | -1.53% |
2023 Q4 | 1.15 Billion TWD | 0.0% |
2022 Q3 | 1.17 Billion TWD | 0.0% |
2022 Q4 | 1.17 Billion TWD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -805.695% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 60.022% |
Level Biotechnology Inc. | 822.67 Million TWD | -40.969% |
Sagittarius Life Science Corp | 664.72 Million TWD | -74.466% |
NeoCore Technology Co., Ltd. | 548.74 Million TWD | -111.338% |
TaiMed Biologics Inc. | 3.89 Billion TWD | 70.217% |
GlycoNex Incorporation | 1.55 Billion TWD | 25.315% |
VBI | 452.1 Million TWD | -156.516% |
GeneReach Biotechnology Corp. | 1.17 Billion TWD | 1.397% |
Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | -54.924% |
SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -206.509% |
Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | -2.282% |
Visgeneer Inc. | 397.17 Million TWD | -191.99% |
Mycenax Biotech Inc. | 3.77 Billion TWD | 69.242% |
Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 46.285% |
G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | -31.324% |
Neith Corporation | 192.15 Million TWD | -503.537% |
Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 80.965% |
TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -1476.599% |
Enimmune corporation | 604.82 Million TWD | -91.743% |
TaiRx, Inc. | 833.74 Million TWD | -39.097% |
CHO Pharma, Inc. | 3.08 Billion TWD | 62.421% |
EirGenix Inc. | 11.16 Billion TWD | 89.611% |
BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | -102.344% |
Sunny Pharmtech Inc. | 1.71 Billion TWD | 32.274% |
Lin BioScience, Inc. | 3.59 Billion TWD | 67.756% |
BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | -10.398% |
Feng Chi Biotech Corp. | 301.03 Million TWD | -285.246% |
Bio Preventive Medicine Corp. | 264.65 Million TWD | -338.195% |
Lukas Biomedical Inc. | 441.19 Million TWD | -162.86% |
RBC Bioscience Corporation | 753.79 Million TWD | -53.851% |
BiOptic Inc. | 613.77 Million TWD | -88.949% |
BRIM Biotechnology, Inc. | 1.77 Billion TWD | 34.799% |
Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | -79.843% |
Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 62.665% |
Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -683.941% |
NaviFUS Corp. | 490.53 Million TWD | -136.418% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | 5.385% |
Sinew Pharma Inc. | 1.36 Billion TWD | 14.938% |
Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -119.167% |
Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | 0.144% |
Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 29.981% |
AP Biosciences Inc | 890.75 Million TWD | -30.194% |
Medigen Biotechnology Corp. | 8.52 Billion TWD | 86.4% |
3D Global Biotech Inc. | 324.14 Million TWD | -257.773% |
Pharmosa Biopharm Inc. | 1.33 Billion TWD | 13.042% |
Intech Biopharm Corporation | 2.71 Billion TWD | 57.223% |
Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 92.452% |
Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -182.679% |
TWi Biotechnology, Inc. | 396.85 Million TWD | -192.229% |
Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 44.135% |
TCI GENE Inc. | 1.16 Billion TWD | 0.534% |
MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -293.683% |
Senhwa Biosciences, Inc. | 1.36 Billion TWD | 14.935% |
Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | -23.143% |
NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | -66.041% |
PharmaEngine, Inc. | 3.95 Billion TWD | 70.669% |
Savior Lifetec Corporation | 3.82 Billion TWD | 69.662% |
TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | 5.702% |
OBI Pharma, Inc. | 5.6 Billion TWD | 79.305% |
Meribank Biotech Co., Ltd | 1.06 Billion TWD | -9.2% |
Acepodia, Inc. | 6.81 Billion TWD | 82.992% |
Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 69.693% |